Abstract

Background. This study was conducted to compare and evaluate the effect of adding lornoxicam or nitroglycerine as adjuncts to lidocaine in intravenous regional anesthesia (IVRA). Methods. 60 patients were randomly separated into three groups, lidocaine group (group L), lidocaine + lornoxicam group (group LL), and lidocaine + lornoxicam + transdermal nitroglycerine group (group LL-N). Hemodynamic parameters, sensory and motor blocks onset, and recovery times were recorded. Analgesic consumption for tourniquet pain and postoperative period were recorded. Results. Sensory block onset times and motor block onset times were shorter in the LL-N and LL groups compared with L group. Sensory block recovery time and motor block recovery time were prolonged in the LL and LL-N groups compared with group L. The amount of fentanyl required for tourniquet pain was less in group LL and group LL-N when compared with group L. VAS scores of tourniquet pain were higher in group L compared with the other study groups. Postoperative VAS scores were higher for the first 4 hours in group L compared with the other study groups. Conclusion. The adjuvant drugs (lornoxicam or TNG) when added to lidocaine in IVRA were effective in improving the overall quality of anesthesia, reducing tourniquet pain, increasing tourniquet tolerance, and improving the postoperative analgesia.

Highlights

  • Intravenous regional anesthesia (IVRA) is widely recommended and applied in patients undergoing ambulatory procedures

  • Sensory block recovery time and motor block recovery time were prolonged in the LL and LL-N groups compared with group L

  • Sensory block onset times were shorter in the LL-N (3.4 ± 0.31 minutes) and LL (5.10 ± 0.38 minutes) groups compared with group L (6.2 ± 0.33 minute) (P < 0.001) and motor block onset times were shorter in the group LL (8.4 ± 1.6 minutes) and group LL-N (4.7 ± 1.2 minutes) compared with group L (11.2 ± 1.5 minutes) (P < 0.0001)

Read more

Summary

Introduction

Intravenous regional anesthesia (IVRA) is widely recommended and applied in patients undergoing ambulatory procedures. Lornoxicam is a new NSAID of the oxicam class which is available in oral and parenteral forms It is a nonopioid analgesic as effective as morphine, tramadol, and meperidine and produces less adverse effects than others [4]. This study was designed to compare and evaluate the effect of adding lornoxicam or both lornoxicam and TNG as adjuncts to lidocaine for IVRA. This study was conducted to compare and evaluate the effect of adding lornoxicam or nitroglycerine as adjuncts to lidocaine in intravenous regional anesthesia (IVRA). VAS scores of tourniquet pain were higher in group L compared with the other study groups. The adjuvant drugs (lornoxicam or TNG) when added to lidocaine in IVRA were effective in improving the overall quality of anesthesia, reducing tourniquet pain, increasing tourniquet tolerance, and improving the postoperative analgesia

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call